The global valvular heart disease market is growing at a considerable CAGR of around 8.0% during the forecast period. The major factors that drive the market growth include the increasing prevalence of coronary artery diseases, cardiovascular disease, and heart attack, Additionally, the increasing geriatric population diagnosed with heart disease is the risk factor for valvular heart disease. The increasing government initiatives on research and development, approval of minimally invasive surgeries, are anticipated to fuel the global valvular heart disease treatment market. For Instance, In April 2019, Boston Scientific Corporation received approval from the US Food and Drug Administration (FDA) for its transcatheter aortic valve replacement (TAVR) technology LOTUS Edge aortic valve system. The technology is used for the patient with severe aortic stenosis and considered high risk for surgical valve replacement via open-heart surgery. The LOTUS Edge valve system is one of the only FDA-approved aortic valves that provides surgeons with the preference to change the position valve and completely recapture the valve once it has been fully deployed.

Free Sample Copy @ https://www.omrglobal.com/request-sample/valvular-heart-diseases-treatment-market

The market is segmented based on diseases, diagnosis, treatment, and end-user. Based on diseases, the market is segmented into aortic valve replacement, heart valve disease, mitral valve stenosis, others (tricuspid valve disorders). Based on diagnosis the market is segmented into cardiac catheterization, electrocardiogram (ECG), chest x-ray, stress testing, others). Based on treatment, the market is segmented into medication, surgery. Based on end-user, the market is segmented into hospitals & clinics, ambulatory surgical centers, research institutes.

A Full Report of Global Valvular Heart Diseases Market is Available at:
https://www.omrglobal.com/industry-reports/valvular-heart-diseases-treatment-market

The global valvular heart diseases market is analyzed based on the geographical regions that are contributing significantly towards the growth of the market. Based on the geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America held a considerable share in 2020 in the global valvular heart disease treatment market. Some factors that are boosting the market growth in North America are the number of cases increases in valvular disorders started increasing North America is the highest contributor of the market. Due to the initiative by the government, and non-government organizations in North America, and reimbursement policies and awareness among the local people also play a vital role in the success of the regional market. Nearly 1.5 million people suffer from aortic stenosis in the US. The presence of the key player in the region, and the increasing number of clinical studies drive the growth of the market in the region.

Global Valvular Heart Diseases Market – Segmentation
by Diseases
Aortic Valve Replacement
Heart Valve Disease
Mitral Valve Stenosis
Others (Tricuspid Valve Disorders)
by Diagnosis
Cardiac Catheterization
Electrocardiogram (ECG)
Chest X-Ray
Stress Testing
Others
by Treatment
Medication
Surgery
Valve Repair
Valve Replacement
by End-Users
Hospital & Clinics
Ambulatory Surgical Centers
Research Institutes

Global Valvular Heart Diseases Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
Abbott Laboratories
B. Braun Melsungen AG
Becton, Dickinson and Co.
Biotronik SE & Co. KG
Boston Scientific Corp.
Braile Biomédica
Cardiac Dimensions Pty. Ltd.
CardiaMed
Cardiosolutions, Inc.
Cook Group Inc.
CryoLife, Inc.
Edwards Lifesciences Corp.
HLT, Inc.
JenaValve Technology, Inc.
Lepu Medical Technology (Beijing) Co., Ltd.
LivaNova PLC
Medtronic, PLC
Micro Interventional Devices, Inc.
NeoChord, Inc.
Neovasc Inc.
ON-X Life Technologies Inc.
Osypka Medical GmbH
Siemens Healthcare Medical Solutions Ltd.
Terumo Corp.
Toray Industries, Inc.
TTK Healthcare Ltd.
Venus Medtech

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/valvular-heart-diseases-treatment-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404